A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer. Researchers say the findings are promising but not yet proof, and clinical trials are now being planned to test whether these drugs could help prevent breast cancer.
source https://www.sciencedaily.com/releases/2026/06/260605023400.htm
Netflix now requires every user profile to be tied to unique email address
-
Recently, my father called me in a panic. There were just a few minutes
until Netflix would start streaming a live MMA event, and he couldn’t get
into my...
5 hours ago
Welcome to the 'The Fact Factory' friends. Its an interesting Hot Spot which brings to you amazing and little known facts from all over the world. So, sit back, take a tour around the world and enjoy the trivia.
No comments:
Post a Comment